| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Ben Dong Huang CEO | SSE Exchange | CNE100004P73 ISIN |
| CN Country | 1,162 Employees | 1 Jul 2026 Last Dividend | 29 May 2025 Last Split | - IPO Date |
Hunan Warrant Pharmaceutical Co.,Ltd is a prominent entity in the pharmaceutical industry, dedicated to manufacturing and distributing an array of pharmaceutical products. With its foundation laid in 2001, the company has anchored its position in Changsha, China, showcasing a significant commitment towards enhancing healthcare through its innovative solutions. The firm operates within a broad spectrum of therapeutic areas, including digestive health, respiratory conditions, infection control, women's health, cardiovascular and cerebrovascular health, immune system support, kidney function, and more, thereby addressing a wide range of medical needs and improving patient outcomes.
The product range offered by Hunan Warrant Pharmaceutical Co.,Ltd encompasses a variety of medicines designed to meet the healthcare needs in several key fields:
Through its comprehensive range of products and services, Hunan Warrant Pharmaceutical Co.,Ltd is committed to advancing healthcare standards and providing effective solutions for an extensive array of medical conditions, thereby contributing to the well-being of communities worldwide.